A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: SARS-CoV-2

In brief

The primary goal for this study is to evaluate up to 3 dose levels of mRNA-1273 vaccine given to healthy children as intramuscular (IM) injection in 2 doses (in Parts 1 and 2) and 3 doses (in Part 3), and a third dose or an optional booster dose (BD) (in Parts 1 and 2).

Key facts

Study ID
NCT04796896
Run by
ModernaTX, Inc.
People needed
11942
Starts
2021-03-15
Expected to finish
2024-03-15
Last updated by the study team
2025-06-13

Who can join

Age: 1 and older, up to 11. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.